| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000033921 |
| Receipt No. | R000038685 |
| Official scientific title of the study | Prospective study for feasibility of monitoring renal blood flow in robot assisted partial nephrectomy |
| Date of disclosure of the study information | 2018/09/01 |
| Last modified on | 2019/02/25 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Prospective study for feasibility of monitoring renal blood flow in robot assisted partial nephrectomy | |
| Title of the study (Brief title) | Monitoring renal blood flow in robot assisted partial nephrectomy | |
| Region |
|
|
| Condition | ||
| Condition | Renal cell carcinoma | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Robot assisted partial nephrectomy was covered by national health insurance in April 2016 in Japan, and is expected to be popularized in the future. Since kidney is a parenchymatous organ, it is necessary to establish avascular state by clamping renal artery, then perform tumor resection, followed by repair of the urinary tract and renal parenchyma for hemostasis. It is desirable to confirm whether the resected area is completely in an ischemic state when clamped, especially in cases where there are multiple renal arteries. Indocyanine green (ICG) is a reagent used for liver function test and cerebral vessel imaging. Intravenous administration of ICG during robot assisted partial nephrectomy allows it to bind with albumin in the blood and irradiate it with laser light, whereby blood flow can be monitored. By using this method, it is possible to know the ischemic state of the entire kidney or the resected area. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Blood loss during surgery |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Indocyanine green (ICG) | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patient with renal cell carcinoma in diameter less than 4cm who can undergo robot assisted partial nephrectomy | |||
| Key exclusion criteria | Patient who had allergic symptoms for Indocyanine green.
Patient with iodine hypersensitivity Patient with allergic factor |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Isao Hara |
| Organization | Wakayama Medical University |
| Division name | Department of Urology |
| Address | 811-1 Kimiidera, Wakayama City |
| TEL | 073-441-0637 |
| hara@wakayama-med.ac.jp | |
| Public contact | |
| Name of contact person | Isao Hara |
| Organization | Wakayama Medical University |
| Division name | Department of Urology |
| Address | 811-1 Kimiidera, Wakayama City |
| TEL | 073-441-0637 |
| Homepage URL | |
| hara@wakayama-med.ac.jp | |
| Sponsor | |
| Institute | Wakayama Medical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Wakayama Medical University |
| Organization | |
| Division | |
| Category of Funding Organization | Local Government |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000038685 |